US BANCORP \DE\ - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,825
+7.9%
1520.0%0.00%
Q2 2023$8,182
+35.5%
1520.0%0.00%
Q1 2023$6,037
-1.3%
1520.0%0.00%
Q4 2022$6,115
+22.3%
1520.0%0.00%
Q3 2022$5,0000.0%152
-12.6%
0.00%
Q2 2022$5,000
-68.8%
174
-69.0%
0.00%
Q1 2022$16,000
-40.7%
562
-2.9%
0.00%
Q4 2021$27,000
+68.8%
579
+21.9%
0.00%
Q3 2021$16,000
+1500.0%
475
+1800.0%
0.00%
Q2 2021$1,0000.0%250.0%0.00%
Q1 2021$1,0000.0%250.0%0.00%
Q3 2020$1,000
-92.3%
25
-93.9%
0.00%
Q2 2020$13,000
-40.9%
408
-24.6%
0.00%
Q1 2020$22,000
+1000.0%
541
+1219.5%
0.00%
Q1 2018$2,000
-60.0%
41
-45.3%
0.00%
Q4 2017$5,000
-77.3%
75
-82.4%
0.00%
Q3 2017$22,000
-88.2%
427
-89.2%
0.00%
-100.0%
Q2 2017$186,000
-56.3%
3,967
-53.8%
0.00%0.0%
Q1 2017$426,000
-14.1%
8,592
+4.9%
0.00%
-50.0%
Q4 2016$496,000
+427.7%
8,187
+473.7%
0.00%
Q3 2016$94,000
+1466.7%
1,427
+1130.2%
0.00%
Q2 2016$6,000
+50.0%
116
-1.7%
0.00%
Q1 2016$4,000
-50.0%
118
-29.8%
0.00%
Q4 2015$8,000
-96.3%
168
-96.9%
0.00%
-100.0%
Q3 2015$216,000
+24.9%
5,487
+9.2%
0.00%0.0%
Q2 2014$173,000
-31.6%
5,023
-37.7%
0.00%0.0%
Q1 2014$253,000
-1.9%
8,063
-37.2%
0.00%0.0%
Q4 2013$258,00012,8480.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 328,494$15,137,0004.72%
TANG CAPITAL MANAGEMENT LLC 300,000$13,824,0002.78%
Mesirow Financial Investment Management, Inc. 12,277$566,0001.63%
Parkman Healthcare Partners LLC 137,226$6,323,0001.40%
Global Alpha Capital Management Ltd. 284,831$13,125,0001.27%
Stonepine Capital Management, LLC 52,290$2,410,0001.11%
1492 Capital Management LLC 43,611$2,010,0000.99%
MARATHON CAPITAL MANAGEMENT 74,770$3,445,0000.81%
Walthausen & Co., LLC 61,456$2,832,0000.74%
Rubric Capital Management LP 307,557$14,172,0000.67%
View complete list of ANI PHARMACEUTICALS INC shareholders